Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2001 1
2002 6
2003 2
2004 4
2005 4
2006 3
2007 6
2008 8
2009 6
2010 9
2011 8
2012 4
2013 8
2014 11
2015 9
2016 7
2017 8
2018 4
2019 12
2020 12
2021 18
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Results by year
Filters applied: . Clear all
Page 1
De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial.
Clark RE, Polydoros F, Apperley JF, Milojkovic D, Rothwell K, Pocock C, Byrne J, de Lavallade H, Osborne W, Robinson L, O'Brien SG, Read L, Foroni L, Copland M. Clark RE, et al. Among authors: byrne j. Lancet Haematol. 2019 Jul;6(7):e375-e383. doi: 10.1016/S2352-3026(19)30094-8. Epub 2019 Jun 12. Lancet Haematol. 2019. PMID: 31201085 Free article. Clinical Trial.
Biomarker Insights Editor-in-Chief Announcement.
Byrne JA. Byrne JA. Biomark Insights. 2020 Apr 9;15:1177271920906676. doi: 10.1177/1177271920906676. eCollection 2020. Biomark Insights. 2020. PMID: 32313424 Free PMC article.
Overexpressed oncogenic tumor-self antigens.
Bright RK, Bright JD, Byrne JA. Bright RK, et al. Among authors: byrne ja. Hum Vaccin Immunother. 2014;10(11):3297-305. doi: 10.4161/hv.29475. Hum Vaccin Immunother. 2014. PMID: 25483660 Free PMC article. Review.
The Experts Speak on Biobank Education.
O'Donoghue S, Byrne JA, Green C, Hill K, Kozlakidis Z, De Wilde A, Mullins P, Wiles KR. O'Donoghue S, et al. Among authors: byrne ja. Biopreserv Biobank. 2020 Feb;18(1):14-17. doi: 10.1089/bio.2020.29064.sod. Biopreserv Biobank. 2020. PMID: 32069096 No abstract available.
We need to talk about systematic fraud.
Byrne J. Byrne J. Nature. 2019 Feb;566(7742):9. doi: 10.1038/d41586-019-00439-9. Nature. 2019. PMID: 30728525 No abstract available.
Predictors of Success of Phase II Pediatric Oncology Clinical Trials.
Franshaw L, Tsoli M, Byrne J, Mayoh C, Sivarajasingam S, Norris M, Marshall GM, Ziegler DS. Franshaw L, et al. Among authors: byrne j. Oncologist. 2019 Aug;24(8):e765-e774. doi: 10.1634/theoncologist.2017-0666. Epub 2019 Feb 26. Oncologist. 2019. PMID: 30808815 Free PMC article. Review.
Urinary markers for prostate cancer.
Downes MR, Byrne JC, Pennington SR, Dunn MJ, Fitzpatrick JM, Watson RW. Downes MR, et al. Among authors: byrne jc. BJU Int. 2007 Feb;99(2):263-8. doi: 10.1111/j.1464-410X.2006.06610.x. Epub 2006 Dec 1. BJU Int. 2007. PMID: 17092277 Review.
A Pathway to Precision Medicine for Aboriginal Australians: A Study Protocol.
Cheng YY, Nunn J, Skinner J, Rambaldini B, Boughtwood T, Calma T, Brown A, Meldrum C, Dinger ME, Byrne JA, McCowen D, Potter J, Faires K, Cooper S, Gwynne K. Cheng YY, et al. Among authors: byrne ja. Methods Protoc. 2021 Jun 21;4(2):42. doi: 10.3390/mps4020042. Methods Protoc. 2021. PMID: 34205718 Free PMC article.
139 results